The Newcastle Joint Research Office (NJRO) has been involved in the conception of a UK-wide database to provide rapid reporting on the incidence of hyper-inflammation in COVID-19 and the association with adverse outcome and potential to be modulated by intervention with biologic therapy. The database provides a rapid means of collating information from multiple sites.
UKRI-funded PhD students whose studies have been disrupted by the COVID-19 pandemic will be provided with additional support.
Wellcome have launched a new webpage with information for anyone applying for a Wellcome research grant or who already holds one.
COVID-19 has placed considerable pressure on clinical trials performed by and in the NHS. National organisations and government bodies have published guidance to ensure that best practice is maintained during this time. The Newcastle upon Tyne Hospitals NHS Foundation Trust (Trust) has a number of SOPs and guidelines to ensure preparedness and maintaining safety for patients and staff. As a research sponsor the Trust has a duty to maintain clinical trial activity where significant safety implications apply. As a result some trials will remain open during the pandemic.
Find out how to get your study nationally supported or funded as high priority COVID-19 Urgent Public Health Research here.
NICE have released their first guidelines and are accumulating the priorities for rapid evidence reviews, which can be viewed https://www.nice.org.uk/covid-19.